SCHEMBL29624993

SCHEMBL29624993

CCOC(=O)c1nc(C)c(N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)n1C

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.34
MAPK1 P28482 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
KMT2A Q03164 1/20 0.33
ABCB1 P08183 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 1/20 0.32
CYP1A2 P05177 2/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
PKM P14618 1/20 0.32
USP2 O75604 1/20 0.31
PDE4D Q08499 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24275809 0.87 SYK (0.33) SYKMAPK1NFKB1NFKB2RELA
SCHEMBL24275808 0.75 SYK (0.38) SYKMAPK1NFKB1NFKB2RELA
SCHEMBL4735920 0.73 CYP3A4 (0.41) SYKKMT2AALDH1A1HPGDCYP1A2
SCHEMBL15052607 0.73 ALDH1A1 (0.38) SYKNFKB1NFKB2RELAKMT2A
SCHEMBL12381778 0.72 KMT2A (0.46) MAPK1KMT2AALDH1A1HPGDCYP1A2
SCHEMBL21608043 0.70 IDO1 (0.39) SYKNFKB1NFKB2RELAKMT2A
SCHEMBL24275860 0.70 GAA (0.40) SYKNFKB1NFKB2RELAKMT2A
SCHEMBL2029380 0.69 HTT (0.41) MAPK1KMT2AALDH1A1HPGDCYP1A2
SCHEMBL16760289 0.68 CRHBP (0.40) SYKMAPK1NFKB1NFKB2RELA
SCHEMBL3382885 0.68 RAB9A (0.51) MAPK1KMT2AABCB1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022053010-A1 FUSED RING PYRIMIDONE DERIVATIVES FOR USE IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES Janssen Sciences Ireland Unlimited Company (IE) 2022-03-17 WO disclosed